4.8 Article

Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting

Journal

CELL METABOLISM
Volume 28, Issue 5, Pages 706-+

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2018.07.021

Keywords

-

Funding

  1. Austrian Science Fund FWF SFB LIPTOX [F3018, P27108, P28854, W1226 DK]
  2. Integrative Metabolism Research Center Graz
  3. Austrian infrastructure program 2016/2017
  4. Lustgarten Foundation
  5. SU2C
  6. Ludwig Center at MIT
  7. NCI [P30 CA1405141, R01 CA168653]
  8. Austrian Marshall Plan Scholarship
  9. Ludwig Center for Molecular Oncology Fund, NSF [GRFP DGE-1122374, T32GM007287]
  10. Damon Runyon Cancer Research Foundation [DRG-2241-15]
  11. CBmed - Center for Biomarker Research in Medicine
  12. NAWI Graz
  13. MIT Center for Precision Cancer Medicine
  14. Austrian Science Fund (FWF) [P27108, P28854] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

Mitochondrial function is important for aspartate biosynthesis in proliferating cells. Here, we show that mitochondrial aspartate export via the aspartate-glutamate carrier 1 (AGC1) supports cell proliferation and cellular redox homeostasis. Insufficient cytosolic aspartate delivery leads to cell death when TCA cycle carbon is reduced following glutamine withdrawal and/or glutaminase inhibition. Moreover, loss of AGC1 reduces allograft tumor growth that is further compromised by treatment with the glutaminase inhibitor CB-839. Together, these findings argue that mitochondrial aspartate export sustains cell survival in low-glutamine environments and AGC1 inhibition can synergize with glutaminase inhibition to limit tumor growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available